Monograph Title | Section Sort descending | Source Publication | Page Number | Errata Post Date | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
DESCRIPTION AND SOLUBILITY | Racemethionine | USP37–NF32 | 1523 | 30-May-2014 | 1-Jun-2014 | USP38–NF33 | USP38–NF33 | Line 6: Change flavors and frangrance. to: flavors and fragrance. |
SODIUM IODIDE I 123 CAPSULES | Radiochemical purity | USP43–NF38 | 2365 | 28-Aug-2020 | 1-Sep-2020 | NA | NA | Change Homogenize 1 Capsule in 3 mL of water, add 3 mL of methanol, and centrifuge: the supernatant so obtained meets the requirements of the test for Radiochemical purity under Sodium Iodide I 123 Solution. to: Place a measured volume of… Read More |
SODIUM IODIDE I 123 CAPSULES | Radionuclide identification | USP43–NF38 | 2365 | 28-Aug-2020 | 1-Sep-2020 | NA | NA | Change A solution or suspension of 1 or more Capsules in water responds to the test for Radionuclide identification under Sodium Iodide I 123 Solution. to: (see Radioactivity <821>) The gamma-ray spectrum of a solution or… Read More |
SODIUM IODIDE I 123 CAPSULES | Radionuclidic purity | USP43–NF38 | 2365 | 28-Aug-2020 | 1-Sep-2020 | NA | NA | Change A solution or suspension of 1 or more Capsules in water responds to the test for Radionuclidic purity under Sodium Iodide I 123 Solution. to: (see Radioactivity <821>) Using a suitable counting assembly, determine the… Read More |
REAGENTS | Reagent Specifications/7,8-Dihydrofolic Acid | Second Supplement to USP41–NF36 | 9052 | 22-Feb-2019 | 1-Mar-2019 | NA | NA | Change (L-Glutamic Acid, N-[4-[[(2-Amino-3,4,7,8-tetrahydro-4-pteridinyl)methyl]amino]benzoyl]-), to: (L-Glutamic Acid, N-[4-[[(2-Amino-3,4,7,8-tetrahydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-), |
REAGENTS AND REFERENCE TABLES | Reagent Specifications/Tosylchloramide Sodium | USPNF Online | Online | 28-Jul-2023 | 1-Aug-2023 | NA | NA | Change 127-65-1 to: 7080-50-4 |
BRINZOLAMIDE | Related compounds/Test 2 | USP35–NF30 | 2385 | 29-Mar-2013 | 1-Apr-2013 | USP37–NF32 | USP37–NF32 | Line 15 of Procedure: Change relative retention time greater than 6. to: relative retention greater than 6. |
NALTREXONE HYDROCHLORIDE | Related compounds | USP39–NF34 | 4985 | 27-May-2016 | 1-Jun-2016 | USP40–NF35 | USP40–NF35 | Line 5: Change 10F(C/W)(rU / rS) to: 1000F(C/W)(rU/rS) |
ORBIFLOXACIN | Related compounds | USP43–NF38 | 3275 | 20-Nov-2020 | 1-Dec-2020 | NA | NA | In Procedure: Change 20,000(CS)(ri/rS)(1/F) in which CS is the concentration, in mg per mL, of orbifloxacin in the Standard solution; ri is… Read More |
FULVESTRANT | Related compounds | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In footnote 1 of table: Change Estra-1,3,5(10)-triene-6-one-3,17-diol,7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-(7α,17β) to: 7α-{9-[(4,4,5,5,5,-Pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-6-one-3,17β-diol AND In footnote 2: Change… Read More |
PREDNISOLONE SODIUM PHOSPHATE | Related compounds | USP41–NF36 | 3416 | 29-Mar-2019 | 1-Apr-2019 | NA | NA | In Table 1: Add Prednisolone sodium phosphate 1.00 — — |
MOXIFLOXACIN OPHTHALMIC SOLUTION | Related compounds | USP36–NF31 | 4414 | 26-Jul-2013 | 1-Aug-2013 | USP38–NF33 | First Supplement to USP37–NF32 | Row 1 of Column 3 of Table 2: Change Relative Retention Time vs. Moxifloxacin to: Relative Retention vs. Moxifloxacin AND Row 1 of Column 3 of Table 3: Change Relative Retention Time vs. Moxifloxacin to: Relative Retention vs. Moxifloxacin |
ONDANSETRON ORAL SOLUTION | Related compounds | USP36–NF31 | 4586 | 28-Mar-2014 | 1-Apr-2014 | USP38–NF33 | USP38–NF33 | Line 7 of Procedure: Change (293.36/329.82)10,000(1 / F)(1 / V)(CS / CA)(ri / rS) to: (293.36 / 329.83)10,000(1 / F)(1 / V)(CS / CA)(ri… Read More |
VALGANCICLOVIR HYDROCHLORIDE | Related compounds | USP42–NF37 | 4528 | 26-Jul-2019 | 1-Aug-2019 | NA | NA | In Column 2 of Table 3: Change Bis-valine easter of ganciclovir to: Bis-valine ester of ganciclovir |
OXANDROLONE | Related compounds | USP41–NF36 | 3072 | 22-Feb-2019 | 1-Mar-2019 | NA | NA | In footnote 4 of the second table: Change Methyl-(1,17β-dihydroxy-17α-methyl-1,3-seco-2-nor-5α-androstane-3-oate. to: Methyl 1,17β-dihydroxy-17α-methyl-1,3-seco-2-nor-5α-androstan-3-oate. |
VINORELBINE INJECTION | Related compounds | USP35–NF30 | 5028 | 29-Mar-2013 | 1-Apr-2013 | USP37–NF32 | USP37–NF32 | Delete the subsection Standard solution and Diluted standard solution. Replace with: Standard solution—Dissolve an accurately weighed quantity of USP Vinorelbine Tartrate RS in Mobile phase to obtain a solution having a known concentration of about 1.4 mg per mL.… Read More |
METRONIDAZOLE | Related compounds | USP35–NF30 | 3905 | 28-Sep-2012 | 1-Oct-2012 | USP37–NF32 | First Supplement to USP36–NF31 | Line 19 of Procedure: Change
ri is the peak response for any unspecified degradation product peak in the Test solution to: ri is the peak response for any single unspecified impurity in the Test solution |
Triclosan | Related compounds | USP35–NF30 | 4939 | 30-Nov-2012 | 1-Dec-2012 | USP37–NF32 | Second Supplement to USP36–NF31 | Line 1 of Procedure: Change Inject a volume (about 0.5 µL) to: Inject a volume (about 2.0 µL) |
MUPIROCIN CREAM | Related compounds/Table 1 | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In footnote 2: Change 9-{(E)-4-[(2R,3aS,6S,7S,8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid. to:… Read More |
MUPIROCIN NASAL OINTMENT | Related compounds/Table 1 | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In footnote 2: Change 9-{(E)-4-[(2R,3aS,6S,7S,8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid. to:… Read More |
Moxifloxacin Ophthalmic Solution | Related compounds/Test 1 | USP35–NF30 | 3960 | 30-Nov-2012 | 1-Dec-2012 | USP37–NF32 | Second Supplement to USP36–NF31 | Line 4 of Chromatographic system: Delete The flow rate is about 0.5 mL per minute. |
AMLODIPINE BESYLATE | Related compounds/Test 2 | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In Chromatographic system: Change Chromatograph the Standard solution, and record the peak responses as directed for Procedure: the standard deviation for replicate injections is not more than 10.0%. to: Chromatograph the … Read More |
CHLOROTHIAZIDE | Selenium <291> | USP42–NF37 | 942 | 26-Jul-2019 | 1-Aug-2019 | NA | NA | Change 0.003%. to: NMT 0.003%. |
DESCRIPTION AND SOLUBILITY | Sodium Acetate | USP37–NF32 | 1525 | 30-May-2014 | 1-Jun-2014 | USP38–NF33 | USP38–NF33 | Line 7: Change transfer liquid. to: transfer ligand. |
REAGENTS AND REFERENCE TABLES | Solutions/Test Solutions and Indicator Solutions/Starch TS | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | Change Prepare this solution by one of the following procedures: to: Prepare this solution by one of the following procedures. Apply the Test for sensitivity to confirm suitability for freshly or previously prepared solutions or commercially bought… Read More |
REAGENTS, INDICATORS AND SOLUTIONS | Solutions/Test Solutions/3. Solutions Prepared Fresh | USP40–NF35 | 2419 | 29-Dec-2017 | 1-Jan-2018 | USP42–NF37 | Second Supplement to USP41–NF36 | Line 2 of 0.06 M Phosphoric Acid TS: Change volumetric flask to: 1000-mL volumetric flask |
REAGENTS, INDICATORS AND SOLUTIONS | Solutions/Volumetric Solutions | Second Supplement to USP39–NF34 | 8458 | 31-Mar-2017 | 1-Apr-2017 | USP41–NF36 | USP41–NF36 | Line 3 of 0.07 N Ferrous Ammonium Sulfate VS: Change In a 100-mL volumetric flask, to: In a 1000-mL volumetric flask, |
REAGENTS | Solutions/Volumetric Solutions/0.01 N Sodium Hydroxide VS | USP41–NF36 | 5770 | 22-Feb-2019 | 1-Mar-2019 | NA | NA | See https://www.uspnf.com/sites/default/files/usp_pdf/EN/february_2019_errata_image1.pdf for correction |
MANNITOL INJECTION | Specific rotation <781> | Second Supplement to USP38–NF33 | Online | 20-Nov-2015 | 1-Dec-2015 | USP40–NF35 | Second Supplement to USP39–NF34 | Line 1: Change Transfer an accurately measured volume of Injection, equivalent to about 1 g of mannitol as determined by the Assay, to a 100-mL volumetric flask:it meets the requirements of the test for Specific rotation under Mannitol. to: +137° to +145°.Transfer… Read More |
CRYOPRESERVED HUMAN FIBROBLAST-DERIVED DERMAL SUBSTITUTE | Total collagen content | USP36–NF31 | 3155 | 26-Jul-2013 | 1-Aug-2013 | USP38–NF33 | First Supplement to USP37–NF32 | Line 7 of Collagen calibration standards: Change by adding 25 mL, 50 mL, 100 mL, and 200 mL, to: by adding 25 μL, 50 μL, 100 μL, and 200 μL, |
<81> Antibiotics—Microbial Assays | Turbidimetric Method | USP35–NF30 | 74 | 30-Nov-2012 | 1-Dec-2012 | USP37–NF32 | Second Supplement to USP36–NF31 | Line 8 of Analysis: Change Include in each rack 1–2 control tubes containing 1 mL of the inoculum medium (see Table 8) but no antibiotic. to: Include in each rack 1–2 control tubes containing 1 mL of the test diluent (see Table 7) but no antibiotic. |
TRIAZOLAM TABLETS | Uniformity of dosage units <905> | USP41–NF36 | 4202 | 28-Dec-2018 | 1-Jan-2019 | NA | NA | In Mobile phase and Chromatographic system: Change Proceed as directed in the Assay under Triazolam. to: Proceed as directed in the Assay. AND In Procedure: Change Proceed as directed for Procedure… Read More |
RACEPINEPHRINE | USP Reference standards <11> | USP41–NF36 | 3564 | 27-Jul-2018 | 1-Aug-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | Add USP Epinephrine Bitartrate RS |
ONDANSETRON INJECTION | USP Reference standards <11> | USP40–NF35 | 5443 | 28-Jul-2017 | 1-Aug-2017 | USP42–NF37 | First Supplement to USP41–NF36 | Line 2 of USP Ondansetron Related Compound A RS: Change 3[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one. to: 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride. |
ONDANSETRON ORAL SOLUTION | USP Reference standards <11> | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | Change USP Ondansetron Related Compound A RS 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride. USP Ondansetron Related Compound C RS 1,2,3,9-Tetrahydro-9-methyl-4H-carbazol-4-one. USP… Read More |
ONDANSETRON | USP Reference standards <11> | USPNF 2021 ISSUE 1 | Online | 31-Dec-2021 | 1-Jan-2022 | NA | NA | Change USP Ondansetron RS USP Ondansetron Related Compound C RS 1,2,3,9-Tetrahydro-9-methyl-4H-carbazol-4-one. USP Ondansetron Related Compound D RS 1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one. to: USP… Read More |
ONDANSETRON ORAL SOLUTION | USP Reference standards <11> | USP40–NF35 | 5444 | 28-Jul-2017 | 1-Aug-2017 | USP42–NF37 | First Supplement to USP41–NF36 | Line 2 of USP Ondansetron Related Compound A RS: Change 3[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one. to: 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride. |
LOVASTATIN | USP Reference standards <11> | USP39–NF34 | 4631 | 29-Jul-2016 | 1-Aug-2016 | USP41–NF36 | First Supplement to USP40–NF35 | Line 2 of USP Lovastatin Related Compound A RS: Change [Dihydro-lovastatin][butanoic acid, 2-methyl-, 1,2,3,4,4a,7,8,8a-octahydro-3,7-dimethyl-8-[2(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1α(R*),3α,7β,8β(2S*,4S*),-8αβ]]]-.… Read More |
ROPIVACAINE HYDROCHLORIDE INJECTION | USP Reference standards <11> | USP43–NF38 | 3945 | 29-May-2020 | 1-Jun-2020 | NA | NA | In USP Ropivacaine Related Compound A RS: Change 2,6-Dimethylaniline hydrochloride. C8H12ClN 157.64 [CAS-21436-98-6]. to: 2,6-Dimethylaniline hydrochloride. C8H11N · HCl 157.64 AND In USP… Read More |
DILUTED ISOSORBIDE MONONITRATE | USP Reference standards <11> | USP38–NF33 | 3973 | 20-Nov-2015 | 1-Dec-2015 | USP40–NF35 | Second Supplement to USP39–NF34 | Line 2 of USP Diluted Isosorbide Mononitrate Related Compound A RS: Change 1,4:3,5-Dianhydro-D-glucitol 2-nitrate. to: 1,4:3,6-Dianhydro-D-glucitol 2-nitrate. |
SALICYLIC ACID | USP Reference standards <11> | USP36–NF31 | 5098 | 27-Sep-2013 | 1-Oct-2013 | USP38–NF33 | First Supplement to USP37–NF32 | Line 3 of USP Salicylic Acid Related Compound A RS: Change [CAS-99-96-7]. to: [99-96-7]. AND Line 3 of USP Salicylic Acid Related Compound B RS: Change C8H6O4 to: C8H6O5 |
RACEPINEPHRINE HYDROCHLORIDE | USP Reference standards <11> | USP41–NF36 | 3565 | 27-Jul-2018 | 1-Aug-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | Add USP Epinephrine Bitartrate RS |
METOPROLOL SUCCINATE | USP Reference standards <11> | USP43–NF38 | 2917 | 29-May-2020 | 1-Jun-2020 | NA | NA | In USP Metoprolol Related Compound C RS: Change (±)4-[2-Hydroxy-3-(1-methylethyl)aminopropoxy]benzaldehyde. C13H19NO3 237.29 to: 4-[2-Hydroxy-3-(isopropylamino)propoxy]benzaldehyde hydrochloride. C13… Read More |
ISOSORBIDE MONONITRATE TABLETS | USP Reference standards <11> | USP38–NF33 | 3974 | 20-Nov-2015 | 1-Dec-2015 | USP40–NF35 | Second Supplement to USP39–NF34 | Line 2 of USP Diluted Isosorbide Mononitrate Related Compound A RS: Change 1,4:3,5-Dianhydro-D-glucitol 2-nitrate. to: 1,4:3,6-Dianhydro-D-glucitol 2-nitrate. |
DACARBAZINE FOR INJECTION | USP Reference standards <11> | USP36–NF31 | 3137 | 26-Jul-2013 | 1-Aug-2013 | USP38–NF33 | First Supplement to USP37–NF32 | Line 3 of USP Dacarbazine Related Compound B RS: Change C4H3N5O 137.10 to: C4H3N5O · H2O 155.12 |
RANITIDINE INJECTION | USP Reference standards <11> | USP39–NF34 | 5670 | 27-May-2016 | 1-Jun-2016 | USP40–NF35 | USP40–NF35 | Line 2 of USP Ranitidine Related Compound C RS: Change N-[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro-1,1-ethenediamine. to: N-{2-[({5-[(Dimethylamino)methyl]-2-furanyl}methyl)sulfinyl]ethyl}-N′-methyl-2-nitro-1,1-… Read More |
RANITIDINE ORAL SOLUTION | USP Reference standards <11> | USP39–NF34 | 5671 | 27-May-2016 | 1-Jun-2016 | USP40–NF35 | USP40–NF35 | Line 2 of USP Ranitidine Related Compound C RS: Change N-[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro-1,1-ethenediamine. to: N-{2-[({5-[(Dimethylamino)methyl]-2-furanyl}methyl)sulfinyl]ethyl}-N′-methyl-2-nitro-1,1-… Read More |
GRANISETRON HYDROCHLORIDE | USP Reference standards <11> | USP39–NF34 | 4151 | 29-Jul-2016 | 1-Aug-2016 | USP41–NF36 | First Supplement to USP40–NF35 | Line 2 of USP Granisetron Related Compound B RS: Change (N-[(1R,3r,5)-9-Methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide). to: (N-[(1R,3r,5S)-9-Methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide). AND… Read More |
GRANISETRON HYDROCHLORIDE INJECTION | USP Reference standards <11> | First Supplement to USP40–NF35 | Online | 31-Mar-2017 | 1-Apr-2017 | USP41–NF36 | USP41–NF36 | Line 3 of USP Granisetron Related Compound C RS: Change carboxamide. to: carboxamide hydrochloride. |
FOSPHENYTOIN SODIUM | USP Reference standards <11> | USP36–NF31 | 3679 | 31-May-2013 | 1-Jun-2013 | USP37–NF32 | USP37–NF32 | Line 6: Change C14H15NO2 to: C14H13NO2 |